Related Experiment Video

Updated: Jun 25, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

DNA damage-dependent cyclin D1 proteolysis: GSK3beta holds the smoking gun

Laura L Pontano1, J Alan Diehl

  • 1The Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

Cell Cycle (Georgetown, Tex.)
|February 18, 2009
PubMed

Insights

DNA damage triggers cyclin D1 degradation via a phosphorylation- and Fbx4-dependent pathway. Disrupting this regulation impairs DNA repair, increases genomic instability, and sensitizes cells to chemotherapy, offering a novel cancer treatment strategy.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Therapeutics

Background:

  • Cyclin D1 accumulates during G1 phase, promoting cell cycle progression.
  • Ubiquitin-mediated degradation of cyclin D1 typically occurs after the G1/S transition.
  • The interplay between cyclin D1 regulation and cellular stress responses, particularly DNA damage checkpoints, is not fully understood.

Purpose of the Study:

  • To investigate the mechanism of cyclin D1 degradation in response to genotoxic stress.
  • To determine the role of this degradation pathway in the cellular response to DNA damage.
  • To explore the therapeutic implications of modulating cyclin D1 regulation in cancer.

Main Methods:

  • Investigated cyclin D1 degradation in response to genotoxic stress.
  • Identified a phosphorylation- and Fbx4-dependent mechanism.
  • Assessed the impact of dysregulated cyclin D1 on DNA damage response and genomic stability.

Main Results:

  • A novel phosphorylation- and Fbx4-dependent pathway for cyclin D1 degradation in response to genotoxic stress was identified.
  • Loss of cyclin D1 regulation was found to compromise the intra-S-phase DNA damage response.
  • Dysregulated cyclin D1 promoted genomic instability and sensitized cells to S-phase chemotherapy.

Conclusions:

  • The identified cyclin D1 degradation pathway is crucial for maintaining genomic stability during DNA damage.
  • Targeting this pathway could represent a therapeutic strategy for cancers with aberrant cyclin D1 accumulation.
  • Understanding cyclin D1 regulation in stress responses offers insights into cancer development and treatment.

More Related Videos

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins10:24

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins

Published on: September 28, 2012

Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay13:10

Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay

Published on: June 9, 2017

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.